ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic	AST_Source
contig_102_38 # 32031 # 33353 # -1 # ID=5_38;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.634	contig_102	32031	33353	-	Strict	600	620.542	Acinetobacter baumannii AbaQ	72.47	3004574	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAGCCAGGAACTGCGGCTTATTCGGCGCATCACGCTGAAACTGATTCCCTTCCTGATCCTGCTGTACCTGATCGCCTACGTGGACCGCTCCGCCGTGGGCTTCGCCAAATTGCACATGGGCGCTGACGTGGGTATCGGTGACGCCGCCTACGGCCTGGGCGCGGGGTTGTTCTTCATTGGCTACTTCCTGTTCGAGATCCCCAGCAACCTGATGCTCGACCGCTTCGGCGCGCGGCGCTGGTTTGCGCGGATCATGATCACCTGGGGCGCCATCACCATCGGCATGGCGTTTGTGCAAGGGCCGCACAGCTTCTACGTGATGCGCTTTCTGCTCGGCGCGGCGGAGGCGGGGTTCTTTCCGGGCGTCCTGTACTACATCACCCAGTGGTTCCCGGTGCGTCATCGCGGCAAGATCCTCGGGCTGTTCATCCTGTCGCAACCCATCGCGATGATGATCACCGGCCCGGTGTCCGGCGGTTTGCTGGGCATGGACGGCATCCTTGGCCTGCACGGCTGGCAGTGGCTGTTCATCGTCATCGGCACCCCGGCGATCCTGCTGACCTGGCCGGTGCTGCGCTACTTGCCGGACGGCCCCAAGCAGGTCAACTGGATGAGCGATGACGAAAAGGCTTGGCTCACCGGCGAACTGGCTAAAGACCTGCAAGCCTACGGCCAGACCCGTCACGGCAACCCGCTGCATGCCCTCAAAGACAAGCGCGTGCTGCTGTTGGCGCTGTTCTACCTGCCGGTGACCCTGAGCATCTACGGCCTGGGCCTGTGGCTGCCGACCCTGATCAAGCAATTCGGCGGCAGCGACCTCACCACCGGCTTTATCTCGGCCGTGCCCTATATCTTCGGCATCATCGGCCTGCTGATCATCCCGCGCAGTTCCGACCGATTGAATGACCGCTACGGCCACCTCGCCGTGCTCTATGTGCTCGGTGCCATCGGCCTGTTCTTCAGTGCCTGGCTGAGTGTGCCGGTGCTGCAAATGGCGGCGCTGTGCCTGGCGGCGTTCGCGATGTTTTCCTGCACGGCGGTGTTCTGGACCCTGCCGGGGCGCTTCTTTGCCGGCGCCAGTGCGGCGGCGGGCATTGCCTTGATCAACTCGGTGGGCAACCTCGGCGGCTACATTGGCCCGTTCGTGATCGGCGCGCTCAAGGAATACACCGGCAACCTGGCTTCGGGCTTGTACTTCCTGTCCGGGGTGATGGTGTTCGGGCTGCTGCTGACCTTCGTGGTCTACCGTGTGCTTGAGCGCAAGCACGTATTGCCTGCCGACCAGTTCGCCGCCAGCGCCCGTGGCGCCACACGTACTTAA	MSQELRLIRRITLKLIPFLILLYLIAYVDRSAVGFAKLHMGADVGIGDAAYGLGAGLFFIGYFLFEIPSNLMLDRFGARRWFARIMITWGAITIGMAFVQGPHSFYVMRFLLGAAEAGFFPGVLYYITQWFPVRHRGKILGLFILSQPIAMMITGPVSGGLLGMDGILGLHGWQWLFIVIGTPAILLTWPVLRYLPDGPKQVNWMSDDEKAWLTGELAKDLQAYGQTRHGNPLHALKDKRVLLLALFYLPVTLSIYGLGLWLPTLIKQFGGSDLTTGFISAVPYIFGIIGLLIIPRSSDRLNDRYGHLAVLYVLGAIGLFFSAWLSVPVLQMAALCLAAFAMFSCTAVFWTLPGRFFAGASAAAGIALINSVGNLGGYIGPFVIGALKEYTGNLASGLYFLSGVMVFGLLLTFVVYRVLERKHVLPADQFAASARGATRT	MDFEKDVIRTVTFKLIPALVILYLVAYIDRAAVGFAHLHMGADVGIGDAAYGLGAGLFFIGYFLFEVPSNLLLDKFGARKWFTRILLTWGLITMAMALIQGPKSFYLLRFLLGVAEAGFFPGVLYLITQWYPVRHRGKIMGMFVLSQPIAMMIAGPLAGLLLGMDGIANLHGWQWLFVAVGLPAVLLALPTFLWLPDNIDKVKWLSIEQKQWLKNELVKDEAEYDQTRHANPLHALKDKRVLLLALYYLPVTLSIYGLNLWLPTIIKQFGGGSDIQIGFLSSIPYIFGIIGLLIIPRSTDRLNDRYGHLSFLYALGACAMFLSGWLNSPVMQLAALAVVAFCLFSSTAVFWTLPGRFLTGASAAAGIALINSVGNLGGYVGPFGIGLLKEYTGNMAAGLYFLSIVMLFGLILTYIVYAKLERQKTQTVNIQKPL	101.38	gnl|BL_ORD_ID|2738|hsp_num:0	3278			0	1275	levofloxacin; nalidixic acid	
contig_104_20 # 12396 # 12806 # -1 # ID=7_20;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.601	contig_104	12396	12806	-	Strict	100	160.614	FosA8	58.82	3007371	protein homolog model	n/a	n/a	phosphonic acid antibiotic	antibiotic inactivation	fosfomycin thiol transferase	ATGCTTTGCGGCTTCAACCACCTGACCCTGGCTGTCACCGACGTGGACCGCAGCGTCCGCTTCTATCATGAGTTGCTGCAACTTCAGCTGGATGCCACATGGGACACCGGCGCGTACCTTTCGCTGCCGGGTCTATGGCTGTGTCTGTCACTCGATCCACTGCGCGACGCCAAGCCGGCGGCCGATTACACCCATTATGCGTTTACCGTCGCGGCGGCTGATTTCACCGCGTTGGTCGCACGCCTGCGAGCAGGTGATGTGCAGGAGTGGCGTGACAACCGCAGCGAAGGGGCGTCGTTCTATTTTCTCGATCCCGATGGCCACAAACTTGAAGCTCATGTCGGTGACCTGGCTTCACGGCTGCGGGCCTGTCGTGCCAAGCCCTATGCGGGAATGAAGTTTTACCCTTAG	MLCGFNHLTLAVTDVDRSVRFYHELLQLQLDATWDTGAYLSLPGLWLCLSLDPLRDAKPAADYTHYAFTVAAADFTALVARLRAGDVQEWRDNRSEGASFYFLDPDGHKLEAHVGDLASRLRACRAKPYAGMKFYP	MLNALNHLTLAVSNLPASITFWRDLLGLRLHAEWHTGAYLTCGDLWLCLSYDETRTFIPPQNSDYTHYAFSVEPEHFDAVAQKLKDAGVTVWKENKSEGASFYFLDPDGHKLELHVGDLAARLAACREKPYAGMVFTSDEA	96.45	gnl|BL_ORD_ID|4921|hsp_num:0	5899			0	408	fosfomycin	
contig_140_24 # 16346 # 19507 # -1 # ID=43_24;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.602	contig_140	16346	19507	-	Strict	750	751.895	adeF	41.37	3000777	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTCGAAATTTTTTATCGACCGTCCCATTTTCGCCTGGGTAATTGCCCTGGTGATCATGCTGGTCGGGGCACTGTCGATCTTGAAGTTGCCCATCAACCAGTACCCGGCCATCGCGCCAACCGCCATCGATATCCAGGTGACCTACCCAGGCGCGTCCGCACAAACCGTGCAGGACACCGTGGTGCAGGTGATCGAGCAACAACTCAACGGTATCGACAACCTGCGTTATGTCGCCTCGGACAGTAACTCCGACGGCAGCATGACCATCACCGCGACGTTCAACCAGGGTACCAACCCGGACATCGCCCAGGTTCAGGTGCAGAACAAGCTGAACCTGGCGACGCCGCTGTTGCCGCAAGAAGTGCAGCAGCAGGGTATCCGCGTCACCAAGTCGGTGAAGAACTTCCTGATGGTGATTGGTCTGGTGTCGGAAGACGGCAGCATGACCAAGGACGATCTGTCCAACTACATCGTGTCCAACATCCAGGACCCGATCTCGCGGACCGCGGGTGTGGGTGACTTCCAGGTCTTCGGCTCGCAGTACGCCATGCGTATCTGGCTGGATCCGGCCAAGCTGAACAACTTCCAGCTGACCCCGGTCGACGTCAGCACCGCCATCTCCGCGCAGAACGTCCAGGTCGCCACCGGTCAATTGGGCGGCCTGCCTGCCCTGCCCGGCAACCAGCTGAACGCAACCATCATCGGCAAGACCCGTCTGCAGACGGCCGAGCAATTCGGCAACATCCTGATGAAGGTCAATGCCGACGGTTCCCAGGTTCGCCTGCATGACATCGCCCGTATCGAACTGGGCGGCCAGAACTACAGCATCAGCGCGCAGTTCAACGGAAACCCGGCTTCCGGTATGGCGATCAAACTGGCTTCCGGCGCCAACGCCCTGGACACCGCCAAGGCCATCCGTGCCACCGTGGCGTCCCTGGAGCCGTTCTTCCCGCCAGGCATGAAGGCGGTGGTGCCGTATGACACCACGCCTGTTGTGACCGAATCGATCTCAGGTGTAGTGCACACCCTGGTCGAAGCGATCGTGCTGGTGTTCCTGGTGATGTTCCTGTTCCTGCAGAACTTCCGCGCCACCATCATCACCACCATGACCGTACCGGTGGTATTGCTGGGTACCTTCGGGATCCTGGCGGCGTTCGGTTTCACCATCAACACCTTGACCATGTTCGGCATGATCCTGGCCATCGGCTTGCTGGTGGACGATGCCATCGTCGTGGTGGAAAACGTCGAGCGGGTCATGGCCGAGGAACACCTGTCGCCCAAGGAGGCGACGGTCAAGTCCATGGGCCAGATCCAGGGCGCCCTGGTGGGTATTGCCCTGGTGCTGTCGGCGGTACTGCTGCCCATGGCATTCTTCGGCGGCTCTACCGGTGTGATCTACAAACAGTTCTCCATCACCATCGTTTCGGCCATGGCGTTGTCGGTACTGGTTGCGCTGATCTTCACCCCGGCCTTGTGCGCCACCATGCTCAAGCCGATCGACCCGGAAAAACACGGCCAACCCAAGCGTGGGTTCTTCGGCTGGTTCAACCGCACCTTCGACCGTGGCGTACTGAGCTACGAGCGCGGCGTGGGCAACATGATCAAGCACAAGATCCCGGCGTTCCTGGTGTACGCGCTGATCTTCGCCGGCATGATCTGGCTGTTCATGCGCATTCCTGCCGCGTTCCTGCCCGATGAAGACCAGGGCGTGATCTTTGCCCAGGTGCAGACGCCTGTAGGCTCTTCGGCTGAACGTACGCAGAAAGTCATCGATGACATGCGTAGCTACCTGCTCAATGACAAGGAAGGCGAGCCGGGCGAAGGCAAAGGCGTGAAATCGGTGTTTACCGTCAACGGCTTCAACTTCGCCGGTCGTGGCCAAAGTTCGGGCCTGGCCTTCGTGATGCTCAAGCCGTGGGATGAACGCGATGCGTCCACCTCGGTATTTGAAATCGCCAAGCGCGCCCAGGGCTACTTCATGCAGACATTCCAGGACGCCATGGTATTTGCCATCGTTCCACCGTCTGTACTGGAACTGGGCAACGCCACCGGTTTCGATGTGTTCCTGCAAGACCAGGGCGGTGTCGGCCATGAGAAGTTGATGGCGGCCCGTAACCAGTTCCTGGGCATGGCGGCCCAGAGCAAGATCCTGGCCGGTGTGCGCCCCAACGGCGTAAACGATGAGCCGCAATACGAGCTTACCGTCGACGACGAGAAGGCCAGCGCCCAAGGCATCACGCTGTCGAACATCAACCAGACCCTGGCAATTGCCCTGGGTGGCAGCTACGTCAACGACTTCATCGACCGTGGTCGAGTGAAGAAGGTGTACGTGCAAGGTGAAGCCGCCAGCCGCATGTCGCCTGAAGACCTGAACAAATGGTACGTGCGCAGCGACTCCGGGAAGATGGTGCCGTTGTCGGCCATCGCGTCGGGCAAGTGGATCTTCGGTTCGCCGAAACTCTCGCGCTACAACGGGGTAGCGGCGATGGAAATCCTCGGCACTCCGGCACCGGGCTACAGTACCGGTGACGCCATGGCCGAAGTCGAACGTATCGCCAAGCAACTGCCTGCGGGCATTGGTTATGCGTGGACCGGCCTGTCGTACGAAGAACGTTTGTCCGGCTCCCAGGCACCTGCGTTGTACGCCTTGTCGCTGCTGGTGGTGTTCCTGTGCCTCGCAGCACTGTACGAAAGCTGGTCGATCCCGATTGCGGTCGTACTGGTCGTGCCACTGGGTGTCGTGGGCGCGTTGATCGCGACCAGCATGCGTGGGTTGTCCAACGACGTGTTCTTCCAGGTGGGCCTATTGGTGACGGTGGGCCTGGCGGCGAAGAACGCCATCCTGATCGTGGAATTCGCCAAAGAACTCCACGAACAAGGCAAAGGCATCGTCGAGGCGGCCATCGAGGCGTCCCGCATGCGTCTGCGGCCGATCATCATGACGTCGATGGCGTTCATCCTCGGCGTACTGCCGCTGGCGATCTCCTCGGGCGCCGGTTCAGGCAGCCAGCACGCAATCGGTACTGGCGTAATTGGCGGTATGATCACGGCCACTGTGTTGGCGATCTTCTGGGTACCGTTGTTCTTCGCAACCGTGTCCGCCATCGGCGACCGTAAACCGAAAGAAACCAAGCAAACTCCTAAAGAGGCTGGCCAATGA	MSKFFIDRPIFAWVIALVIMLVGALSILKLPINQYPAIAPTAIDIQVTYPGASAQTVQDTVVQVIEQQLNGIDNLRYVASDSNSDGSMTITATFNQGTNPDIAQVQVQNKLNLATPLLPQEVQQQGIRVTKSVKNFLMVIGLVSEDGSMTKDDLSNYIVSNIQDPISRTAGVGDFQVFGSQYAMRIWLDPAKLNNFQLTPVDVSTAISAQNVQVATGQLGGLPALPGNQLNATIIGKTRLQTAEQFGNILMKVNADGSQVRLHDIARIELGGQNYSISAQFNGNPASGMAIKLASGANALDTAKAIRATVASLEPFFPPGMKAVVPYDTTPVVTESISGVVHTLVEAIVLVFLVMFLFLQNFRATIITTMTVPVVLLGTFGILAAFGFTINTLTMFGMILAIGLLVDDAIVVVENVERVMAEEHLSPKEATVKSMGQIQGALVGIALVLSAVLLPMAFFGGSTGVIYKQFSITIVSAMALSVLVALIFTPALCATMLKPIDPEKHGQPKRGFFGWFNRTFDRGVLSYERGVGNMIKHKIPAFLVYALIFAGMIWLFMRIPAAFLPDEDQGVIFAQVQTPVGSSAERTQKVIDDMRSYLLNDKEGEPGEGKGVKSVFTVNGFNFAGRGQSSGLAFVMLKPWDERDASTSVFEIAKRAQGYFMQTFQDAMVFAIVPPSVLELGNATGFDVFLQDQGGVGHEKLMAARNQFLGMAAQSKILAGVRPNGVNDEPQYELTVDDEKASAQGITLSNINQTLAIALGGSYVNDFIDRGRVKKVYVQGEAASRMSPEDLNKWYVRSDSGKMVPLSAIASGKWIFGSPKLSRYNGVAAMEILGTPAPGYSTGDAMAEVERIAKQLPAGIGYAWTGLSYEERLSGSQAPALYALSLLVVFLCLAALYESWSIPIAVVLVVPLGVVGALIATSMRGLSNDVFFQVGLLVTVGLAAKNAILIVEFAKELHEQGKGIVEAAIEASRMRLRPIIMTSMAFILGVLPLAISSGAGSGSQHAIGTGVIGGMITATVLAIFWVPLFFATVSAIGDRKPKETKQTPKEAGQ	MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIAETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVSQAMPRLPEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLFGSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGRLTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANALQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAITLVVVVVILFLQTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIEAGLNPREATYRAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVISAFNSLTLSPALAALLLKGHDAKPDALTRIMNRVFGRFFALFNRVFSRASDRYSQGVSRVISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKMSDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQKYSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGPMFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQADAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGYSSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYESLTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFARELEMQGATAFKAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVTFFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH	99.43	gnl|BL_ORD_ID|132|hsp_num:0	153			6	3123	tetracycline	
contig_141_145 # 108846 # 109940 # -1 # ID=44_145;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.601	contig_141	108846	109940	-	Strict	250	255.758	vanG	37.19	3002909	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; Van ligase	ATGAGCAAGGTGCGGGTAGGTATTATTTTTGGTGGCCGTTCGGCGGAGCATGAAGTCTCGTTGCAATCGGCGCGCAATATTGTCGATGCACTCGACCGTACGCGCTTCGAGCCGGTCCTGATCGGTATCGACAAGGCCGGCCACTGGCACCTCAACGACACCTCGAACTTCCTGCTCAACCAGGAAAATCCGGCCCTGATCGCGCTCAACCAGTCCAATCGCGAACTGGCTGTAGTGCCCGGCAAGGCCAGCCAGCAACTGGTGGAAACCTCAGGCACGGGCCTGTTGGAACATGTCGATGTGATCTTCCCCATCGTCCACGGCACCCTCGGCGAAGACGGCTGCCTGCAAGGGCTGTTGCGCATGGCTGACCTGCCTTTCGTCGGCTCCGACGTACTTGGCTCGGCGGTGTGCATGGACAAGGACATCAGCAAGCGCTTGCTGCGCGATGCCGGCATCGCCGTTACCCCGTTTATCACGCTGACCCGCAGCAATGCCACGCGCACGTCCTTCGATACGGCGGTGAACACGCTCGGCCTGCCGATGTTCGTTAAACCGGCCAACCAAGGTTCGTCTGTAGGCGTGAGTAAAGTCGGCACCGAAGCCGAGTACCACGCTGCCGTTGAACTGGCCCTGGGCTTTGATGAAAAGGTGTTGGTTGAGTCCGCCGTAAAGGGCCGTGAAATCGAATGCGCCGTGTTGGGCAATGAGCACCCCATCGCCAGCGGGTGTGGTGAGATCGTGGTGAGCAGCGGTTTCTATTCCTACGACAGCAAATATATCGACGACCAGGCCGCCCAAGTGGTGGTGCCGGCCGCTATCAGCCATGACGCCAGCGAGCGCATTCGTGGACTGGCCATTGAGGCGTTCGAGGTGCTGGGCTGTTCCGGTTTGGCGCGGGTCGACGTGTTTCTCACCGACGACGGCAACGTGCTGATCAACGAAATCAACTCACTGCCCGGCTTCACCCGTATCAGCATGTACCCCAAACTGTGGCAGGCAGCGGGCATGAGCTACAGCGAACTGGTGAGCCGCTTGATCGAGCTGGCGCTGGAACGGCATGCGGGGCGCAAGGGGTTGAAGATCAGTCGCTGA	MSKVRVGIIFGGRSAEHEVSLQSARNIVDALDRTRFEPVLIGIDKAGHWHLNDTSNFLLNQENPALIALNQSNRELAVVPGKASQQLVETSGTGLLEHVDVIFPIVHGTLGEDGCLQGLLRMADLPFVGSDVLGSAVCMDKDISKRLLRDAGIAVTPFITLTRSNATRTSFDTAVNTLGLPMFVKPANQGSSVGVSKVGTEAEYHAAVELALGFDEKVLVESAVKGREIECAVLGNEHPIASGCGEIVVSSGFYSYDSKYIDDQAAQVVVPAAISHDASERIRGLAIEAFEVLGCSGLARVDVFLTDDGNVLINEINSLPGFTRISMYPKLWQAAGMSYSELVSRLIELALERHAGRKGLKISR	MQNKKIAVIFGGNSTEYEVSLQSASAVFENINTNKFDIIPIGITRSGEWYHYTGEKEKILNNTWFEDSKNLCPVVVSQNRSVKGFLEIASDKYRIIKVDLVFPVLHGKNGEDGTLQGIFELAGIPVVGCDTLSSALCMDKDRAHKLVSLAGISVPKSVTFKRFNEEAAMKEIEANLTYPLFIKPVRAGSSFGITKVIEKQELDAAIELAFEHDTEVIVEETINGFEVGCAVLGIDELIVGRVDEIELSSGFFDYTEKYTLKSSKIYMPARIDAEAEKRIQEAAVTIYKALGCSGFSRVDMFYTPSGEIVFNEVNTIPGFTSHSRYPNMMKGIGLSFSQMLDKLIGLYVE	104.30	gnl|BL_ORD_ID|1065|hsp_num:0	1157			0	1047	vancomycin	
contig_22_22 # 14996 # 15184 # -1 # ID=54_22;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.524	contig_22	14996	15184	-	Strict	100	100.138	rsmA	80.33	3005069	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCTGATTCTGACTCGTCGTTGCGCAGAAAGCCTGATTATCGGTGATGGCGAAATCACCGTGACCGTGCTCGGCGTCAAAGGCAATCAAGTACGTATCGGGGTTAACGCTCCGAAAGAGGTAGCGGTGCACCGCGAGGAAATCTACCTGCGGATCAAGAAAGAGAAGGACGAAGAACCAAGCCTTTAA	MLILTRRCAESLIIGDGEITVTVLGVKGNQVRIGVNAPKEVAVHREEIYLRIKKEKDEEPSL	MLILTRRVGETLMVGDDVTVTVLGVKGNQVRIGVNAPKEVAVHREEIYQRIQKEKDQEPNH	101.64	gnl|BL_ORD_ID|2813|hsp_num:0	3807			0	180	trimethoprim; chloramphenicol	
contig_32_1447 # 1465458 # 1468586 # -1 # ID=63_1447;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.652	contig_32	1465458	1468586	-	Strict	750	770.385	adeF	43.6	3000777	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCCGCAATTCTTCATCGATCGCCCGGTATTCGCCTGGGTGGTCGCACTGTTCATCCTGCTGGCTGGCGCGCTGGCCATCCCGCAACTGCCGGTGGCCCAGTACCCCAACGTGGCACCGCCGCAGGTGGAAATCTACGCCGTGTACCCGGGTGCCTCGGCGGCGACCATGGACGAAAGCGTGGTCAGCCTGATCGAACAGGAGCTCAACGGCGCCGACAACCTGCTGTACTTCGAGTCGCAGAGCAGCCTGGGCAGCGCCACCATCACCGCCACCTTCGCCCCGGGTACCCACCCGGACCTGGCCCAGGTCGACGTGCAGAACCGCCTGAAAGTGGTCGAGTCGCGCCTGCCGCGCCCGGTCACCCAGCAGGGCCTGCAGGTGGAGAAAGTGTCCACCGGCTTCCTGCTGTTGGCGACCCTCACCTCCGAAGACGGCAAGCTCGATGAAACCGCGCTGTCGGACATCCTTGCACGTAACGTGATGGACGAGATCCGCCGCCTCAAGGGCGTCGGCAAGGCCCAGTTGTATGGCTCCGAACGGGCCATGCGCATCTGGATCGACCCGCGCAAGCTGATCGGTTTCAACCTCACGCCCAACGATGTAGCCGAAGCCATCGCCGCGCAGAACGCCCAGGTCGCCCCTGGCAGCATCGGCGATCTGCCCAGCCGCAGCACCCAGGAAATCACCGCCAACGTGGTGGTCAAAGGCCAGTTGAGCAGCCCCGACGAGTTTGCTGCCATTGTCCTGCGTGCCAACCCGGACGGCTCCACGGTCACCATCGGGGATGTCGCCCGGGTTGAAATCGGTGCCCAGGAATACCAGTACGGCACGCGCCTGAACGGCAAACCGGCCACGGCCTTCAGCGTGCAGTTGTCACCCGGCGCCAACGCCATGGAAACCGCTACCCTGGTACGGGCGAAGATGCAGGACCTGGCGCGCTACTTCCCGGAAGGCGTCAAGTACGACATCCCCTACGACACCTCGCCGTTCGTCAAGGTGTCGATCGAGCAGGTCATCAACACCCTGTTCGAGGCCATGCTGCTGGTGTTCGCAGTCATGTTCCTGTTCCTGCAGAACCTGCGCTACACGCTGATCCCGACCCTGGTCGTGCCAGTGGCATTGATGGGCACCTTCGCCGTGATGCTGGCCATGGGCTTCTCGGTCAATGTGCTGACACTGTTCGGCATGGTGCTGGCCATCGGCATTCTGGTCGACGATGCCATCGTGGTGGTGGAGAACGTCGAGCGCATCATGGCCGAAGAAGGCTTGCCGCCCAAGCAAGCCACGCGCAAGGCCATGGGCCAGATCAGCGGTGCAATCGTCGGCATCACGCTGGTGCTGGTGGCGGTATTCCTGCCCATGGCCTTCATGCAAGGCTCGGTGGGGGTGATCTACCAGCAGTTCTCGCTGTCGATGGCGGTGTCGATCCTGTTCTCGGCGTTTCTCGCCCTCAGCCTGACCCCGGCATTGTGCGCCACCCTGCTCAAGCCCGTGGCCAAGGGCGAGCACCATGAACGCAAAGGCTTCTTCGGCTGGTTCAATCGCCGCTTCGAAAGCATGAGCAACGGCTACCAGCGCTGGGTAGTGCAGGCGCTCAAGCGCAGCGGCCGCTACCTGCTGGTGTACGCGGTGCTGCTGGCGGTGCTGGGCTACGGTTTCAGCCAGCTGCCTACGGCGTTCCTGCCTACCGAAGACCAAGGCTACACCATCACCGACATTCAGCTGCCGCCGGGCGCCAGCCGCATGCGCACCGAACAGGTAGCCGCGCAGATCGAGGCGCACAACGCCGAAGAACCGGGCGTGGGCAACACCACCTTGATCCTCGGCTTCAGCTTCTCCGGTAGCGGGCAGAACGCGGCGCTGGCCTTCACCACCCTCAAGGACTGGTCCGAGCGCGGCGCCGACGACAGCGCCCAGTCGATCGCCGACCGCGCGACCATGGCCTTCACCCAGCTCAAGGACGCGATTGCCTATTCGGTACTGCCGCCCCCCATTGACGGCCTCGGTGAGTCGACCGGTTTCGAATTTCGCCTTCAGGACCGTGGCGGCATGGGCCACGCCGAGCTGATGGCAGCCCGTGACCAGCTGCTCGAAAGCGCCAGCAAAAGCAAGGTGCTGACCAACGTGCGCGAAGCCTCGCTGGCGGAAAGCCCGCAGGTGCAACTGGAAATCGACCGCCGCCAGGCTAATGCACTGGGTGTGTCGTTTGCCGATATCGGCACGGTGCTGGACGTGGCCGTGGGCTCCAGCTACGTCAACGATTTCCCCAACCAGGGCCGCATGCAGCGGGTGGTGGTGCAGGCCGAAGGTGACCAGCGCAGCCAGGTCGAAGACTTGCTGAACATTCACGTGCGCAACGACAGCGGCAAGATGGTGCCACTGGGCGCGTTCGTGCAGGCCAGGTGGGTCAGCGGCCCGGTGCAACTGACCCGCTACAACGGTTACCCGGCGGTGTCGATCTCAGGCGAGCCTGCCGCCGGCTACAGCTCGGGCGAGGCCATGGCCGAAGTCGAGCGGCTGGTGGCGCAGCTACCGGCCGGTACCGGTCTGGAATGGACCGGCCTGTCACTGCAGGAGCGGCTGTCCGGTAGCCAGGCCCCCCTGCTGATGGCGCTGTCGCTGCTGGTGGTGTTCCTGTGCCTGGCAGCGCTGTACGAAAGCTGGTCGATCCCGACTGCGGTGCTGCTGGTCGTTCCGCTCGGTGTGCTCGGTGCGGTGCTGGCGGTGACCTTGCGCGGCATGCCCAACGACGTGTTCTTCAAGGTTGGCCTGATTACCCTGATCGGCCTGTCGGCGAAGAACGCCATCCTGATCATCGAGTTCGCCAAGCATCTGGTTGACCAGGGCGTGGACGCCGCCGACGCCGCCGTGCAAGCGGCCCGCCTGCGCCTGCGGCCGATCGTGATGACGTCGCTGGCGTTCATCCTCGGCGTGGTGCCCCTGGCCATCGCCAGCGGCGCAAGCTCTGCCAGCCAGCAGGCGATTGGCACCGGGGTGATCGGCGGCATGCTCAGCGCCACCCTGGCGGTGGTGTTCGTGCCGGTGTTCTTCGTGGTGGTGATGCGCCTGTCCGGGCGACGCCAGGCGCATGACAGCGACGGGCAACCCGTGCCCCGCGAAAGCTGA	MPQFFIDRPVFAWVVALFILLAGALAIPQLPVAQYPNVAPPQVEIYAVYPGASAATMDESVVSLIEQELNGADNLLYFESQSSLGSATITATFAPGTHPDLAQVDVQNRLKVVESRLPRPVTQQGLQVEKVSTGFLLLATLTSEDGKLDETALSDILARNVMDEIRRLKGVGKAQLYGSERAMRIWIDPRKLIGFNLTPNDVAEAIAAQNAQVAPGSIGDLPSRSTQEITANVVVKGQLSSPDEFAAIVLRANPDGSTVTIGDVARVEIGAQEYQYGTRLNGKPATAFSVQLSPGANAMETATLVRAKMQDLARYFPEGVKYDIPYDTSPFVKVSIEQVINTLFEAMLLVFAVMFLFLQNLRYTLIPTLVVPVALMGTFAVMLAMGFSVNVLTLFGMVLAIGILVDDAIVVVENVERIMAEEGLPPKQATRKAMGQISGAIVGITLVLVAVFLPMAFMQGSVGVIYQQFSLSMAVSILFSAFLALSLTPALCATLLKPVAKGEHHERKGFFGWFNRRFESMSNGYQRWVVQALKRSGRYLLVYAVLLAVLGYGFSQLPTAFLPTEDQGYTITDIQLPPGASRMRTEQVAAQIEAHNAEEPGVGNTTLILGFSFSGSGQNAALAFTTLKDWSERGADDSAQSIADRATMAFTQLKDAIAYSVLPPPIDGLGESTGFEFRLQDRGGMGHAELMAARDQLLESASKSKVLTNVREASLAESPQVQLEIDRRQANALGVSFADIGTVLDVAVGSSYVNDFPNQGRMQRVVVQAEGDQRSQVEDLLNIHVRNDSGKMVPLGAFVQARWVSGPVQLTRYNGYPAVSISGEPAAGYSSGEAMAEVERLVAQLPAGTGLEWTGLSLQERLSGSQAPLLMALSLLVVFLCLAALYESWSIPTAVLLVVPLGVLGAVLAVTLRGMPNDVFFKVGLITLIGLSAKNAILIIEFAKHLVDQGVDAADAAVQAARLRLRPIVMTSLAFILGVVPLAIASGASSASQQAIGTGVIGGMLSATLAVVFVPVFFVVVMRLSGRRQAHDSDGQPVPRES	MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIAETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVSQAMPRLPEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLFGSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGRLTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANALQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAITLVVVVVILFLQTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIEAGLNPREATYRAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVISAFNSLTLSPALAALLLKGHDAKPDALTRIMNRVFGRFFALFNRVFSRASDRYSQGVSRVISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKMSDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQKYSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGPMFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQADAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGYSSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYESLTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFARELEMQGATAFKAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVTFFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH	98.39	gnl|BL_ORD_ID|132|hsp_num:0	153			12	3165	tetracycline	
contig_32_1474 # 1503457 # 1506636 # -1 # ID=63_1474;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.630	contig_32	1503457	1506636	-	Strict	750	1369.76	adeF	67.24	3000777	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAACTTCTCGAAATTCTTCATTACCCGGCCGATCTTCGCCGCGGTGCTGTCGCTGGTGCTGCTGATCGCGGGTTCCATCTCGCTGTTCCAGCTGCCGATCAGCGAATACCCCGAAGTGGTGCCGCCCACCGTGGTGGTGCGCGCCAACTTCCCCGGCGCCAACCCCAAGGTCATCGGCGAAACCGTTGCCGCGCCGCTGGAGCAGGCCATTACCGGTGTGGAGAACATGCTGTACATGTCCTCCCAGTCCACTGCGGACGGCAAGCTGACGCTGACCATCACCTTCGCCCTGGGTACCGACCTGGACAACGCCCAGGTGCAGGTGCAGAACCGCGTCACCCGTACCCAGCCCAAGCTGCCCGAGGAAGTGACCCGTATCGGTATCACCGTCGACAAGGCCTCGCCTGACCTGACCATGGTCGTGCACCTGACCTCGCCGGACAACCGCTACGACATGCTCTATCTGTCCAACTACGCCATCCTCAACATCAAGGACGAGCTGGCGCGCCTGGGCGGCGTAGGCGACGTGCAGCTGTTTGGCATGGGCGACTACTCGCTGCGCGTCTGGCTGGACCCGAACAAGACCGCTTCGCGCAACCTGACGGCCAGTGATGTGGTCGCGGCAATCCGCGAGCAGAACCGCCAGGTGGCCGCCGGCCAGCTGGGCGCGCCGCCTGCCCCAGGCTCGACCAGCTTCCAGCTGTCGATCAATACCCAAGGCCGCCTGGTCAACGAGGAAGAGTTCGAAAACATCATCATCCGCGCCGGTGCCGATGGCGAGATCACCCGCCTGAAAGACATCGCCCGGGTCGAACTCGGCTCCAGCCAGTACGCCCTGCGCTCGCTGCTGAACAACCAGCCGGCGGTGGCCATCCCGATTTTCCAGCGCCCAGGCTCCAACGCCATCGAGATCTCCGACGAAGTGCGGGCGAAAATGGCCGAGCTGAAAAAGGACTTCCCGGAAGGGATGGACTACAGCATCGTCTATGACCCGACCATCTTCGTGCGCGGCTCCATCGAAGCGGTGGTGCACACCCTGTTCGAAGCCCTGGTGCTGGTGGTGCTGGTGGTGATCCTGTTCCTGCAGACCTGGCGCGCCTCGATCATCCCGCTGCTGGCGGTGCCGGTCTCGCTGATCGGTACCTTCGCGGTCATGCACCTGTTCGGTTTTTCACTTAACGCGCTGTCGTTATTCGGGCTGGTGCTCGCCATCGGTATCGTGGTGGACGATGCCATCGTCGTGGTGGAGAACGTCGAACGTAACATCGGGCTGGGCCTGAAACCGCTGGAAGCCACGCAAAAGGCCATGAGCGAAGTGACCGGCCCGATCATCGCCACCGCCCTGGTGCTGTGCGCGGTGTTCGTACCTGCAGCGTTCATTTCCGGCCTTACCGGGCAGTTCTACAAGCAGTTCGCCCTGACCATCGCCATCTCGACCGTCATTTCGGCGTTCAACTCGCTGACCCTGTCGCCAGCCTTGGCCGCGGTGCTGCTCAAGGATCATCACGCACCCAAGGACCGTTTCTCGCGGTTCCTCGACAAGCTGCTGGGCAGCTGGCTGTTCTCCCCTTTCAACCGGTTCTTCGACCGGGCCAGCCACAGCTACGTCGGTGGCGTGCGCCGGGTCATCCGCTCCAGCGGCATCGCCCTGTTCGTGTATGCCGGCCTGATGGGTCTGACCTACCTCGGCTTCTCGTCCACGCCGACCGGTTTCGTGCCGGCCCAGGACAAGCAGTACCTGGTGGCCTTCGCCCAACTGCCGGACGCGGCCAGCCTCGACCGTACCGAAGCGGTGATCAAGCGCATGAGCGAAATCGCCCTGAAGCAGCCTGGCGTGGCCGACTCGGTAGCCTTCCCGGGCCTGTCGATCAACGGTTTCACCAACAGCCCCAACAGCGGCATCGTGTTCACCCCGCTCAAACCATTCGATGAGCGCAAGGACCCGAGCCAGTCGGCGGCAGCCATCGCAGCCGCGCTGAATGCCCAGTTCGCCGACATCCAGGACGCCTACATCGCCATCTTCCCACCGCCGCCGGTACAGGGCCTGGGCACGATTGGCGGGTTCCGTCTGCAAATCGAAGACCGTGGCAACCTGGGTTACGAAGCGCTGTACAAGGAAACCCAGAACATCATCGCCAAGAGCCACAACGTCCCAGAGCTGGCAGGCCTGTTCACCAGCTACCAGGTCAACGTGCCACAAGTCGATGCCGCCATCGACCGGGAAAAGGCCAAGACCCACGGTGTGGCGATCACCGACATCTTCGACACCCTGCAGGTTTACCTGGGCTCGCTGTACACCAACGACTTCAACCGCTTTGGCCGCACTTACCAGGTCAACGTCCAGGCCGAGCAGCAGTTCCGCCTTGATGCCGAGCAGATCGGCCAACTGAAAGTGCGCAACAACCTTGGCGAGATGATCCCGCTGGCGACCTTCCTCAAGGTCAGCGACACCTCCGGGCCGGACCGGGTCATGCACTACAACGGCTTCATCACTGCCGAGATCAACGGCGCTGCCGCCCCGGGCTACAGCTCTGGTCAGGCGGAAGCTGCGATCGAGAAGCTGCTGAAGGAAGAACTGCCCAACGGCATGACCTTCGAGTGGACCGACCTGACCTACCAGCAGATCCTCTCGGGCAATACCGCATTGCTGGTGTTCCCGCTGTGCGTACTGCTGGCGTTCCTGGTGCTGGCCGCCCAGTACGAAAGCTGGAGCCTGCCGCTGGCGGTGATCCTGATCGTGCCGATGACCCTGCTGTCGGCCATCACCGGTGTGATCGTATCGGGTGGCGACAACAACATCTTCACCCAGATCGGCCTGATCGTACTGGTGGGCCTGGCGTGCAAGAACGCGATCCTGATCGTCGAGTTCGCCAAGGACGAACAGGCCAAGGGCCTCGACCCGCTGGCTGCGGTACTGGAAGCCTGCCGCCTGCGCCTGCGGCCGATCCTGATGACCTCGATCGCCTTCATCATGGGTGTGGTGCCCCTGGTGTTCAGCTCCGGCGCAGGTTCGGAAATGCGCCATGCCATGGGGGTGGCGGTGTTCTCGGGGATGATCGGCGTGACCGTGTTCGGCCTGTTCCTCACCCCGGTGTTCTTCTTCCTGATCCGCCGTTTCGTCGAGCGTCGCCAGGCCCGCAAGGCTGAACACGCTCAAGTGCTGGAGAACCACGCATGA	MNFSKFFITRPIFAAVLSLVLLIAGSISLFQLPISEYPEVVPPTVVVRANFPGANPKVIGETVAAPLEQAITGVENMLYMSSQSTADGKLTLTITFALGTDLDNAQVQVQNRVTRTQPKLPEEVTRIGITVDKASPDLTMVVHLTSPDNRYDMLYLSNYAILNIKDELARLGGVGDVQLFGMGDYSLRVWLDPNKTASRNLTASDVVAAIREQNRQVAAGQLGAPPAPGSTSFQLSINTQGRLVNEEEFENIIIRAGADGEITRLKDIARVELGSSQYALRSLLNNQPAVAIPIFQRPGSNAIEISDEVRAKMAELKKDFPEGMDYSIVYDPTIFVRGSIEAVVHTLFEALVLVVLVVILFLQTWRASIIPLLAVPVSLIGTFAVMHLFGFSLNALSLFGLVLAIGIVVDDAIVVVENVERNIGLGLKPLEATQKAMSEVTGPIIATALVLCAVFVPAAFISGLTGQFYKQFALTIAISTVISAFNSLTLSPALAAVLLKDHHAPKDRFSRFLDKLLGSWLFSPFNRFFDRASHSYVGGVRRVIRSSGIALFVYAGLMGLTYLGFSSTPTGFVPAQDKQYLVAFAQLPDAASLDRTEAVIKRMSEIALKQPGVADSVAFPGLSINGFTNSPNSGIVFTPLKPFDERKDPSQSAAAIAAALNAQFADIQDAYIAIFPPPPVQGLGTIGGFRLQIEDRGNLGYEALYKETQNIIAKSHNVPELAGLFTSYQVNVPQVDAAIDREKAKTHGVAITDIFDTLQVYLGSLYTNDFNRFGRTYQVNVQAEQQFRLDAEQIGQLKVRNNLGEMIPLATFLKVSDTSGPDRVMHYNGFITAEINGAAAPGYSSGQAEAAIEKLLKEELPNGMTFEWTDLTYQQILSGNTALLVFPLCVLLAFLVLAAQYESWSLPLAVILIVPMTLLSAITGVIVSGGDNNIFTQIGLIVLVGLACKNAILIVEFAKDEQAKGLDPLAAVLEACRLRLRPILMTSIAFIMGVVPLVFSSGAGSEMRHAMGVAVFSGMIGVTVFGLFLTPVFFFLIRRFVERRQARKAEHAQVLENHA	MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIAETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVSQAMPRLPEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLFGSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGRLTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANALQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAITLVVVVVILFLQTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIEAGLNPREATYRAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVISAFNSLTLSPALAALLLKGHDAKPDALTRIMNRVFGRFFALFNRVFSRASDRYSQGVSRVISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKMSDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQKYSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGPMFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQADAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGYSSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYESLTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFARELEMQGATAFKAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVTFFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH	100.00	gnl|BL_ORD_ID|132|hsp_num:0	153			0	3138	tetracycline	
contig_32_3802 # 3804056 # 3807208 # 1 # ID=63_3802;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.618	contig_32	3804056	3807208	+	Strict	750	758.829	adeF	40.96	3000777	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTCGAAGTTCTTTATCGATCGCCCGATCTTCGCCTGGGTGATCGCCTTGGTGATCATGCTGGTCGGGGCCTTGTCCATCCTGAAGCTGCCGATCAACCAGTACCCCAGTATCGCGCCGCCAGCCATCGCCATCGCCGTGACCTACCCGGGCGCCTCGGCGCAAACCGTGCAGGACACCGTGGTGCAGGTGATCGAGCAGCAGCTCAACGGTATCGACAACCTGCGTTATGTGTCGTCGGAAAGTAACTCCGACGGCAGCATGACCATTACCGCCACCTTCGAACAGGGCACCAACCCCGACACCGCGCAGGTACAGGTACAGAACAAGCTGAACCTGGCCACCCCGCTGCTGCCGCAGGAAGTGCAGCAGCAAGGTATCCGCGTCACCAAAGCAGTGAAGAACTTCCTGCTGGTGATCGGCCTGGTCTCCGAAGACGGCAGCATGACCAAGGACGACCTGGCCAACTATATCGTCTCGAACATGCAGGACCCGATCTCGCGTACCGCGGGTGTAGGTGACTTCCAGGTGTTCGGTGCGCAGTACGCCATGCGTATCTGGCTCGATCCGGCCAAGCTGAATAAGTTCCAGCTGACCCCGGTCGACGTCAAGACCGCTGTGGCCGCACAGAACGTGCAGGTGTCTTCCGGCCAGCTCGGCGGCCTGCCAGCCCTGCCGGGCACCCAGCTGAACGCCACCATCATCGGCAAGACCCGCCTGCAAACCGCCGAGCAGTTCGAGAGTATCCTGCTCAAGGTCAACAAAGACGGTTCACAGGTGCGCCTGGGCGATGTCGCCCAAGTAGGCCTGGGGGGTGAAAACTACGCCGTCAGCGCCCAGTTCAACGGCAAGCCGGCTTCCGGCCTGGCGGTAAAACTGGCAACCGGCGCCAACGCGCTGGACACCGCCAAGGCACTGCGCGAGACCATCAAAGGCCTGGAACCGTTCTTCCCGCCGGGAGTCAAGGCGGTATTCCCGTATGACACCACCCCAGTGGTCACCGAATCGATCAGCGGCGTGATCCACACCCTGATCGAAGCCGTGGTGCTGGTGTTCCTGGTGATGTACCTGTTCCTGCAGAACTTCCGCGCCACCATCATCACCACCATGACCGTACCGGTGGTATTGCTGGGTACCTTCGGCATCCTTGCCGCCGCGGGCTTCAGCATCAACACCCTGACCATGTTCGCCATGGTTCTGGCCATCGGCTTGCTGGTGGACGACGCCATCGTCGTGGTGGAGAACGTCGAGCGGGTCATGTCCGAGGAAGGCTTGCCGCCCAAGGAAGCGACCAAACGCTCGATGGAACAGATCCAGGGCGCCCTGGTGGGTATCGCCCTGGTGCTCTCGGCCGTACTGCTGCCCATGGCGTTCTTTGGCGGCTCCACGGGTGTGATCTACCGGCAGTTCTCCATCACCATCGTCTCGGCCATGGGCCTGTCGGTGCTGGTTGCGCTGATCTTCACCCCGGCGCTCTGCGCAACCATGCTCAAACCGCTGAAGAAGGGCGAGCACCACACCGCCAAAGGTGGCTTCTTCGGCTGGTTCAACCGCAACTTCGACCGCAGCGTCAACGGCTACGAGCGCAGTGTAGGCGCCATCTTGCGCAACAAGGTGCCATTCCTGCTGGCCTATGCGCTGATCGTGGTCGGCATGATCTGGCTGTTCGCCCGCATCCCTACCGCGTTCCTGCCAGAAGAAGACCAGGGCGTACTGTTCGCTCAGGTGCAGACCCCGGCCGGCTCCAGTGCCGAACGCACGCAGGTCGTGGTCGACCAGATGCGTGAATACCTGCTCAAGGACGAAGCCGATACCGTATCGTCGGTGTTCACGGTCAACGGTTTCAACTTCGCAGGCCGCGGCCAGAGCTCGGGCATGGCCTTCATCATGCTCAAACCCTGGGATGAACGCTCGAAGGAAAACAGCGTGTTCGCCCTGGCCCAGCGTGCCCAGCAGCACTTCTTTACCTTCCGTGATGCGATGGTGTTCGCCTTCGCCCCGCCAGCGGTGCTTGAACTGGGTAACGCCACCGGCTTCGACGTGTTCCTTCAGGACCGCGGCGGTGTCGGCCACGAGAAGTTGATGGAGGCGCGCAACCAGTTCCTGGCCAAAGCTGCGCAGAGCAAGATCCTCAGCGCCGTGCGCCCGAACGGCCTGAACGATGAACCGCAGTACCAGCTGACCATTGATGACGAACGTGCCAGCGCCCTGGGCGTGACCATTGCCGACATCAACAACACCCTGTCGATTGCCTTGGGTGCCAGCTACGTCAACGACTTCATCGACCGTGGCCGGGTCAAGAAGGTGTACATCCAGGGCGAACCCAGCGCGCGGATGAGCCCGGAAGACCTGCAAAAATGGTACGTGCGCAACGGCGCAGGGGAGATGGTGCCGTTCTCCTCCTTCGCCAAAGGCGAATGGACCTACGGTTCGCCGAAGCTGTCGCGTTACAACGGTGTCGAAGCGATGGAAATCCTCGGTGCACCGGCGCCTGGCTACAGTACCGGTGAAGCCATGGCCGAGGTCGAGCGCATTGCAGGCGAGCTGCCAAGCGGTATCGGCTTCTCCTGGACCGGCATGTCCTACGAGGAAAAACTCTCCGGCTCGCAGATGCCGGCGCTGTTCGCCCTCTCGGTGCTGTTCGTGTTCCTGTGCCTGGCGGCCCTGTACGAAAGCTGGTCGATCCCGATCGCTGTGGTGCTGGTAGTACCGCTGGGTATCATCGGTGCGCTGATCGCCACCAGCCTGCGCGGCCTGTCCAACGACGTGTACTTCCTGGTTGGCCTGTTGACCACCATCGGTCTTGCGGCGAAAAACGCCATTCTGATCGTGGAATTCGCCAAGGAGCTGCACGAACAAGGCCGCAGCCTGTACGACGCAGCGATCGAGGCGTGCCGCATGCGTCTGCGCCCGATCATCATGACCTCGCTGGCGTTCATCCTGGGCGTGGTACCGTTGACCATCGCCAGCGGCGCCAGCGCCGGCAGCCAGCACGCCATCGGTACTGGCGTGATCGGCGGCATGATCAGTGCGACCGTGCTGGCTATCTTCTGGGTACCACTGTTCTTCGTCGCAGTGTCGTCGCTGTTCGGCAGCAAAGAGCCGGAAAAAGACGTCACCCCTGAAAATCCACGTTATGAGGCTGGGCAATGA	MSKFFIDRPIFAWVIALVIMLVGALSILKLPINQYPSIAPPAIAIAVTYPGASAQTVQDTVVQVIEQQLNGIDNLRYVSSESNSDGSMTITATFEQGTNPDTAQVQVQNKLNLATPLLPQEVQQQGIRVTKAVKNFLLVIGLVSEDGSMTKDDLANYIVSNMQDPISRTAGVGDFQVFGAQYAMRIWLDPAKLNKFQLTPVDVKTAVAAQNVQVSSGQLGGLPALPGTQLNATIIGKTRLQTAEQFESILLKVNKDGSQVRLGDVAQVGLGGENYAVSAQFNGKPASGLAVKLATGANALDTAKALRETIKGLEPFFPPGVKAVFPYDTTPVVTESISGVIHTLIEAVVLVFLVMYLFLQNFRATIITTMTVPVVLLGTFGILAAAGFSINTLTMFAMVLAIGLLVDDAIVVVENVERVMSEEGLPPKEATKRSMEQIQGALVGIALVLSAVLLPMAFFGGSTGVIYRQFSITIVSAMGLSVLVALIFTPALCATMLKPLKKGEHHTAKGGFFGWFNRNFDRSVNGYERSVGAILRNKVPFLLAYALIVVGMIWLFARIPTAFLPEEDQGVLFAQVQTPAGSSAERTQVVVDQMREYLLKDEADTVSSVFTVNGFNFAGRGQSSGMAFIMLKPWDERSKENSVFALAQRAQQHFFTFRDAMVFAFAPPAVLELGNATGFDVFLQDRGGVGHEKLMEARNQFLAKAAQSKILSAVRPNGLNDEPQYQLTIDDERASALGVTIADINNTLSIALGASYVNDFIDRGRVKKVYIQGEPSARMSPEDLQKWYVRNGAGEMVPFSSFAKGEWTYGSPKLSRYNGVEAMEILGAPAPGYSTGEAMAEVERIAGELPSGIGFSWTGMSYEEKLSGSQMPALFALSVLFVFLCLAALYESWSIPIAVVLVVPLGIIGALIATSLRGLSNDVYFLVGLLTTIGLAAKNAILIVEFAKELHEQGRSLYDAAIEACRMRLRPIIMTSLAFILGVVPLTIASGASAGSQHAIGTGVIGGMISATVLAIFWVPLFFVAVSSLFGSKEPEKDVTPENPRYEAGQ	MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIAETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVSQAMPRLPEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLFGSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGRLTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANALQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAITLVVVVVILFLQTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIEAGLNPREATYRAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVISAFNSLTLSPALAALLLKGHDAKPDALTRIMNRVFGRFFALFNRVFSRASDRYSQGVSRVISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKMSDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQKYSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGPMFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQADAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGYSSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYESLTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFARELEMQGATAFKAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVTFFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH	99.15	gnl|BL_ORD_ID|132|hsp_num:0	153			6	3156	tetracycline	
contig_73_11 # 15841 # 16290 # 1 # ID=101_11;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.620	contig_73	15841	16290	+	Strict	200	212.616	Pseudomonas aeruginosa soxR	71.13	3004107	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penicillin beta-lactam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic target alteration; antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCTGAACAAGGAACTCACCGTCGGCCAACTCGCCGCCCGCAGTGGTGTGGCCGTCACGGCGTTGCATTTCTACGAGACCAAGGGGCTGATCAAGAGTAATCGCAATGCCGGTAACCAACGGCGTTATCCACGGGATGTGTTGCGGCGCGTGGTGGTGATCAAGATCGCCCAGCGCCTGGGGATTCCGCTGGCAACGATTGGCGAAGCGTTGCAGGCGTTGCCGGAGGGGCGCACACCCAACGCCCGGGATTGGGAACGCTTATCGGCGCTATGGCGGGAAGACCTGGATGAGCGCATCAACAAGCTGACGCTGCTGCGCGACACACTCAATGGCTGTATTGGCTGTGGGTGCTTATCGATGGAGGCGTGTCCGTTGCGCAATCAGGGCGACAAGCTCGGTGAGTGCGGTCCGGGCGCCCAACTGCTGGAGCCCACTCCACACCGCTGA	MLNKELTVGQLAARSGVAVTALHFYETKGLIKSNRNAGNQRRYPRDVLRRVVVIKIAQRLGIPLATIGEALQALPEGRTPNARDWERLSALWREDLDERINKLTLLRDTLNGCIGCGCLSMEACPLRNQGDKLGECGPGAQLLEPTPHR	MKNSCASRELSVGELARRAGVAVSALHFYETKGLISSQRNAGNQRRFSRETLRRVVVIKVAQRVGIPLAEIARALQTLPAGRSPSAADWARLSAQWKEDLTERIDKLLLLRDQLDGCIGCGCLSLQACPLRNPGDQLSAEGPGAHWLDAEGREHDG	95.51	gnl|BL_ORD_ID|2400|hsp_num:0	2775			18	444	tigecycline; ciprofloxacin; tetracycline; rifampin; chloramphenicol; ampicillin; norfloxacin; cefalotin; triclosan	
